GlucoTrack
GCTK
13 hedge funds and large institutions have $104K invested in GlucoTrack in 2026 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
30% more funds holding
Funds holding: 10 → 13 (+3)
8.79% more ownership
Funds ownership: 7.02% → 15.81% (+8.8%)
58% less capital invested
Capital invested by funds: $248K → $104K (-$144K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$99.8K |
| 2 |
HF
HRT Financial
New York
|
+$86.3K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.41K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.24K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$2 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$108 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $30.6K | +$99.8K | +47,001 | New |
|
|
IC
2
Ikarian Capital
Dallas,
Texas
| $29.8K | – | – | – |
|
|
HF
3
HRT Financial
New York
| $26K | +$86.3K | +40,631 | New |
|
|
BFM
4
Boothbay Fund Management
New York
| $8.79K | – | – | – |
|
|
VFT
5
Vanguard Fiduciary Trust
Malvern,
Pennsylvania
| $3.07K | +$10K | +4,722 | New |
|
|
AF
6
Alerus Financial
Grand Forks,
North Dakota
| $2.6K | – | – | – |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $2.24K | +$6.41K | +3,017 | +710% |
|
|
8
UBS Group
Zurich,
Switzerland
| $456 | +$1.24K | +583 | +490% |
|
|
NFSG
9
Newbridge Financial Services Group
Boca Raton,
Florida
| $22 | – | – | – |
|
|
SS
10
SBI Securities
Tokyo,
Japan
| $6 | – | – | – |
|
11
Morgan Stanley
New York
| $1 | – | – | – |
|
|
12
Osaic Holdings
Scottsdale,
Arizona
| $1 | +$2 | +1 | +100% |
|
|
13
Bank of America
Charlotte,
North Carolina
| – | -$108 | -28 | Closed |
|
14
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$2 | +1 | New |
|
GCTK Hedge Fund Activity: Q1 2026 in Review
13 of the 8,132 institutional investors tracked by Wall St. Rank reported a position in GlucoTrack (GCTK) for Q1 2026, worth a combined $104K — down 58% from $248K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new GCTK positions and 1 closed out — a net gain of 3 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $99.8K. The largest seller was Bank of America, exiting entirely with an estimated $108 sold.
- 13 institutional investors held GlucoTrack (GCTK) as of Q1 2026, up from 10 in Q4 2025.
- Funds reported $104K of GlucoTrack stock for Q1 2026, down 58% quarter-over-quarter.
- 4 funds opened new GlucoTrack positions in Q1 2026 and 1 closed out, a net change of +3 holders.
- The largest GlucoTrack buyer in Q1 2026 was Geode Capital Management, an estimated $99.8K added.
- The largest GlucoTrack seller in Q1 2026 was Bank of America, an estimated $108 sold.
Based on aggregated 13F filings for Q1 2026.